Evaluation of subconjunctival oculusgen implantation as an adjunct to trabeculectomy

Iranian Journal of Ophthalmology

Volumn 22, Issue 2, 2010, Pages 55-62

  Nilforushan, Naveed ^a   Yadgari, Maryam ^a   Falavarjani, Khalil Ghasemi ^a   Afshar, Arash Ehteshami ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glaucoma; Mitomycin c; Oculusgen; Trabeculectomy

Indexed keywords

EID: 77954504970     PISSN: 2345279x     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K 1983;103(Pt 1):84-8.
2. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101(5):795-8.
3. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J ophthalmol 1992;114(5):544-53.
4. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003;48(3):314-46.
5. Zelefsky JR, Hsu WC, Ritch R. Biodegradable collagen matrix implant for trabeculectom. Expert Rev Ophthalmol 2008;3(6):613-7.
6. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin- C in refractory glaucoma. J Ocul Pharmacol 1990;6(3):175-82.
7. Lee DA, Shapourifar-Tehrani S, Kitada S. The effect of 5-fluorouracil and cytarabine on human fibroblasts from Tenon's capsule. Invest Ophthalmol Vis Sci 1990;31(9):1848-55.
8. Lee DA, Lee TC, Cortes AE, Kitada S. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990;31(10):2136-44.
9. Lee DA. Antifibrosis agents and glaucoma surgery. Invest Ophthalmol Vis Sci 1994;35(11):3789-91.
10. Khaw PT, Doyle JW, Sherwood MB, et al. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993;111(2):263-7.
11. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1995;102(9):1263-9.
12. D'Ermo F, Bonomi L, Doro D. A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol 1979;88(5):829-35.
13. Inaba Z. Long-term results of trabeculectomy in the Japanese: an analysis by life-table method. Jpn J Ophthalmol 1982;26(4):361-73.
14. Huygens M, Vercruysse K, Goethals M, Missotten L. Trabeculectomy: a retrospective long-term follow-up study. Bull Soc Belge Ophtalmol 1990;238:125-35.
15. Thommy CP, Bhar IS. Trabeculectomy in Nigerian patients with open-angle glaucoma. Br J Ophthalmol 1979;63(9):636-42.
16. Schwartz PL, Ackerman J, Beards J, et al. Further experience with trabeculectomy. Ann Ophthalmol 1976;8(2):207-17.
17. Singh K, Egbert PR, Byrd S, et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol 1997;123(1):48-53.
18. Tham CC, Lai JS, Poon AS, et al. Results of mrabeculectomy with adjunctive intraoperative Mitomycin C in Chinese patients with glaucoma. Ophthalmic Surg Lasers Imaging 2006;37(1):33-41.
19. Fontana H, Nouri-Mahdavi K, Lumba J, et al. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology 2006;113(6):930-6.
20. Hong SJ, Wu KY, Wang HZ, Lai YH. Toxic effects of mitomycin-C on cultured ciliary process cells and trabecular meshwork cell. J Ocul Pharmacol Ther 2001;17(4):331-42.
21. Mietz H, Roters S, Krieglstein GK, Bullous keratopathy as a complication of trabeculectomy with mitomycin -C. Graefes Arch Clin Exp Ophthalmol 2005;243(12):1284-7.
22. Sauder G, Jonas JB, Limbal stem cell deficiency after subconjunctival Mitomycin C injection for trabeculectomy. Am J Ophthalmol 2006;141(6):1129-30.
23. Chen HS, Rich R, Krupin T, et al. Control of filtering bleb structure through tissue bioengineering: An animal model. Invest Ophthalmol Vis Sci 2006;47(12):5310-4.
24. Scott IU, Greenfield DS, Schiffman J, et al. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 1998;116:286-91.
25. Murthy SK, Damji KF, Pan Y, Hodge WG. Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. Can J Ophthalmol 2006;41:51-9.
26. Cheung JC, Wright MM, Murali S, et al. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997;104(1):143-9.